nanofiber expansion of umbilical cord blood hematopoietic stem cells
Authors
abstract
background the aim of this study was the ex vivo expansion of umbilical cord blood hematopoietic stem cells on biocompatible nanofiber scaffolds. materials and methods cd133+ hematopoietic stem cells were separated from umbilical cord blood using midimacs (positive selection) system by means of monocolonal antibody cd133 (microbeads) subsequently, flowcytometry method was done to assess the purity of separated cells. isolated cells were cultured on plate (2 dimensional) and fibronectin conjugated polyethersulfon nanofiber scaffold, simultaneously (3 dimensional). colony assay test was performed to show colonization ability of expanded cells. results cell count analysis revealed that expansion of hematopoietic stem cells in 2dimensional (2d) environment was greater than 3dimensional (3d) condition (p =0.01). assessment of stem cell- phenotype after expansions was performed by flowcytometric analysis which is showed that the maintenance of cd133 marker in expanded cells in 3 dimensional condition were higher than expanded cells in 2 dimensional condition (p=0.01). moreover, colony assay test was performed before and after of expansion to show colonization ability of expanded cells both in 3d and 2d culture and results revealed more ability of 3d culture compared with 2d culture (p =0.03). conclusion the results of current study confirmed that umbilical cord blood cd133+ haematopoietic stem cells are able to expand on fibronectin conjugated polyethersulfon scaffold. these findings indicated that 3d is a proper and valuable cell culture system for hematopoietic stem cells expansion, compared to 2d in invitro situation.
similar resources
Nanofiber Expansion of Umbilical Cord Blood Hematopoietic Stem Cells
Background The aim of this study was the ex vivo expansion of Umbilical Cord Blood hematopoietic stem cells on biocompatible nanofiber scaffolds. Materials and Methods CD133+ hematopoietic stem cells were separated from umbilical cord blood using MidiMacs (positive selection) system by means of monocolonal antibody CD133 (microbeads) subsequently, flowcytometry method was done to asses...
full textNanofiber Expansion of Umbilical Cord Blood Hematopoietic Stem Cells.
BACKGROUND The aim of this study was the ex vivo expansion of Umbilical Cord Blood hematopoietic stem cells on biocompatible nanofiber scaffolds. MATERIALS AND METHODS CD133+ hematopoietic stem cells were separated from umbilical cord blood using MidiMacs (positive selection) system by means of monocolonal antibody CD133 (microbeads); subsequently, flowcytometry method was done to assess the ...
full textAdvances and challenges in storage, transplantation, expansion and homing of Umbilical Cord Blood Hematopoietic Stem Cells (UCB-HSCs)
Abstract Background and Objectives Umbilical cord blood hematopoietic stem cells (UCB-HSCs) have high potential capabilities in the treatment of hematological and non-hematological disorders. Awareness of biology, self-renewal, homing, expansion, storage, and transplantation can lead to optimal use of these cells. Materials and Methods In this Review article in order to investigate the adv...
full textEx Vivo Expansion of Umbilical Cord Blood Hematopoietic Stem Cells on Collagen- Fibronectin Coated Electrospun Nano Scaffold
Background and Objective: Umbilical Cord blood (UCB) hematopoietic stem cell (HSC) transplantation is a therapeutic approach for the treatment of malignant and non-malignant hematologic disorders due to ease of collection, lack of risk for donors and lower levels of infection. Moreover, it is considered a good alternative for bone marrow HSC transplantation. The main limitation of their use is ...
full textexpansion of cd133(+) umbilical cord blood derived hematopoietic stem cells on a biocompatible microwells.
umbilical cord blood (ucb) as a source of hematopoietic stem/progenitor cells (hspcs) used for umbilical cord blood transplantation (ucbt). the main obstacle in application of this source as an appropriate source of hspcs is low volume of this product. so ex vivo expansion of these cells in a microenvironment which mimic body condition is important. in current study we designed biocompatible mi...
full textCharacteristics of hematopoietic stem cells of umbilical cord blood
Umbilical cord blood collected from the postpartum placenta and cord is a rich source of hematopoietic stem cells (HSCs) and is an alternative to bone marrow transplantation. In this review we wanted to describe the differences (in phenotype, cytokine production, quantity and quality of cells) between stem cells from umbilical cord blood, bone marrow and peripheral blood. HSCs present in cord b...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of pediatric hematology and oncologyجلد ۵، شماره ۴، صفحات ۱۷۰-۱۷۸
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023